Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
Background The quadrivalent and bivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to …
licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to …
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
C Patel, JML Brotherton, A Pillsbury… - …, 2018 - eurosurveillance.org
Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …
Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data
Objective To measure the effect on genital warts of the national human papillomavirus
vaccination programme in Australia, which started in mid-2007. Design Trend analysis of …
vaccination programme in Australia, which started in mid-2007. Design Trend analysis of …
Integrating clinical, community, and policy perspectives on human papillomavirus vaccination
Infection with genital human papillomavirus (HPV) may cause anogenital cancers,
oropharyngeal cancers, anogenital warts, and respiratory papillomas. Two prophylactic …
oropharyngeal cancers, anogenital warts, and respiratory papillomas. Two prophylactic …
Development and psychometric properties of the HPV Impact Profile (HIP) to assess the psychosocial burden of HPV
TC Mast, X Zhu, C Demuro-Mercon… - … medical research and …, 2009 - Taylor & Francis
Objective: A comprehensive questionnaire designed to assess the full spectrum of potential
human papillomavirus (HPV)-related psychosocial effects in women does not exist. The HPV …
human papillomavirus (HPV)-related psychosocial effects in women does not exist. The HPV …
The psychological impact of illness among women experiencing human papillomavirus-related illness or screening interventions
KL Wang, CJ Jeng, YC Yang, CA Chen… - Journal of …, 2010 - Taylor & Francis
The present study describes the psychological impact of human papillomavirus (HPV)-
related conditions or preventive interventions on Taiwanese women. Women with an HPV …
related conditions or preventive interventions on Taiwanese women. Women with an HPV …
[HTML][HTML] The impact of HPV multi-cohort vaccination: real-world evidence of faster control of HPV-related morbidity
M Orumaa, SK Kjaer, C Dehlendorff, C Munk, AO Olsen… - Vaccine, 2020 - Elsevier
Abstract Background In 2009, both Norway and Denmark initiated routine quadrivalent
human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also …
human papillomavirus vaccination (qHPV) for 12-year-old girls; however, Denmark also …
[HTML][HTML] Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: potential …
S Hartwig, JJ Baldauf, G Dominiak-Felden… - Papillomavirus …, 2015 - Elsevier
Introduction A second generation HPV vaccine has been developed for the prevention of
anogenital cancers and precancerous lesions of the cervix, vulva, vagina, anus and of …
anogenital cancers and precancerous lesions of the cervix, vulva, vagina, anus and of …
Human papillomavirus vaccination in males
AR Giuliano - Gynecologic oncology, 2007 - Elsevier
Human papillomavirus (HPV) is one of the most common sexually transmitted diseases
(STDs) and is frequently presented clinically as anogenital warts in both males and females …
(STDs) and is frequently presented clinically as anogenital warts in both males and females …
Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study
D Mesher, K Panwar, SL Thomas, S Beddows… - BMJ open, 2016 - bmjopen.bmj.com
Objectives The human papillomavirus (HPV) immunisation programme in England was
introduced in 2008. Monitoring changes in type-specific HPV prevalence allows assessment …
introduced in 2008. Monitoring changes in type-specific HPV prevalence allows assessment …